Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

TET2 gene expression and 5-hydroxymethylcytosine level in multiple sclerosis peripheral blood cells.
Experiences of functional electrical stimulation (FES) and ankle foot orthoses (AFOs) for foot-drop in people with multiple sclerosis.
Over-the-counter anti-oxidant therapies for use in multiple sclerosis: A systematic review.
Biointegrator announced that it has successfully launched Neskler® - a first generic of Gilenya® in Russia and EuroAsian Economic Union
Isolated new onset 'atypical' optic neuritis in the NMO clinic: serum antibodies, prognoses and diagnoses at follow-up.
7 tesla magnetic resonance imaging to detect cortical pathology in multiple sclerosis.
Neuromyelitis optica in pregnancy complicated by posterior reversible encephalopathy syndrome, eclampsia and fetal death.
The mediating effect of coping on the association between fatigue and quality of life in patients with multiple sclerosis.
Long-term management of natalizumab discontinuation in a large monocentric cohort of multiple sclerosis patients.
Multiple sclerosis patient-derived CSF induces transcriptional changes in proliferating oligodendrocyte progenitors.
Clostridium perfringens Epsilon Toxin Causes Selective Death of Mature Oligodendrocytes and Central Nervous System Demyelination.
Quality of life reporting in multiple sclerosis clinical trials: enough quality?
Jacksonian seizure as the relapse symptom of multiple sclerosis.
The risks for falls and fractures in multiple sclerosis.
Is It Too Early to Predict the Failure of Natalizumab in NMO?
Exosomes in neurologic and psychiatric disorders.
Contemporary treatment options for relapsing-remitting multiple sclerosis.
Single nucleotide polymorphisms with cis-regulatory effects on long non-coding transcripts in human primary monocytes.
Occurrence of a multiple sclerosis-like illness in women who have a Leber's hereditary optic neuropathy mitochondrial DNA mutation.
The blood-brain barrier-permeable catechol-O-methyltransferase inhibitor dinitrocatechol suppresses experimental autoimmune encephalomyelitis.
Expression Analysis of CB2-GFP BAC Transgenic Mice.
Multidisciplinary management of multiple sclerosis symptoms.
Acceptance of the Extracare Program by Beta Interferon-Treated Patients With Multiple Sclerosis: Results of the Explore Study.
Comparative analysis of treatment outcomes in patients with neuromyelitis optica spectrum disorder using multifaceted endpoints.
[Fingolimod compassionate use program : Case study on the concept of a therapy option for multiple sclerosis prior to marketing approval.]

Pages